Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Prostatic Neoplasms 9Leukemia, Myeloid, Acute 9Endometrial Neoplasms 8Breast Neoplasms 7Oropharyngeal Neoplasms 5Neoplasm Metastasis 5Lung Neoplasms 5Colonic Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Multiple Myeloma 4Melanoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Congenital Abnormalities 4Colorectal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 3Neuroblastoma 3Mouth Neoplasms 3Lymphoma, Follicular 3Leukemia 3Esophageal Neoplasms 3Brain Neoplasms 3

Interventions

Doxorubicin 15Exercise 9Cyclophosphamide 9Dexrazoxane 8Razoxane 6Carvedilol 6Vincristine 4Trastuzumab 4Radiotherapy 4Filgrastim 4Docetaxel 4Methotrexate 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Echocardiography 3Atorvastatin 3salicylhydroxamic acid 2sacubitril and valsartan sodium hydrate drug combination 2empagliflozin 2dapagliflozin 2Tablets 2Silymarin 2Prednisone 2Paclitaxel 2Neoadjuvant Therapy 2Leucovorin 2Ivabradine 2High-Intensity Interval Training 2Epirubicin 2Electrocardiography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cardiotoxicity × Observation × Clear all
NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡